Shortening Development and Approval Timelines for Novel Medicinal Products
In this infographic, we highlight the benefits of twelve key special designations, many of which shorten development and approval
timelines for novel medicinal products. However, these are not always granted. Veristat experts recommend that you build a strategic regulatory plan and leverage the right pathways to ensure a seamless regulatory strategy and submission plan for both U.S. and global registrations. Overall, these regulatory pathways can save time and reduce the cost of bringing therapies to market—and to patients—sooner.
Explore Our Key Related Services
Please fill out this form to access your resource.